Medical technology firm TELA Bio, Inc. has today announced its mission to deliver effective, soft-tissue reconstruction solutions through prioritizing the restoration and preservation of a patient's anatomy. Offering a comprehensive portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction, as well as OviTex PRS Reinforced Tissue Matrix products suitable for plastic and reconstructive surgery, TELA Bio is committed to advancing and addressing the unmet needs within this sector. Moreover, the company provides an innovative solution, OviTex for Laparoscopic and Robotic Procedures - a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber designed specifically for laparoscopic and robotic-assisted hernia surgical repairs. As TELA Bio seeks to expand its US-based direct sales force, the Pennsylvania-headquartered firm remains committed to executing on its bold mission to optimize clinical outcomes for patients worldwide.
TELA Bio's ticker is TELA
The company's shares trade on the NASDAQ stock exchange
They are based in Malvern, Pennsylvania
There are 51-200 employees working at TELA Bio
It is telabio.com
TELA Bio is in the Healthcare sector
TELA Bio is in the Medical Appliances & Equipment industry
The following five companies are TELA Bio's industry peers: